Literature DB >> 15181033

Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study.

Nanette Santoro1, Bill Lasley, Dan McConnell, Jenifer Allsworth, Sybil Crawford, Ellen B Gold, Joel S Finkelstein, Gail A Greendale, Jenny Kelsey, Stan Korenman, Judith L Luborsky, Karen Matthews, Rees Midgley, Lynda Powell, Janice Sabatine, Miriam Schocken, Mary Fran Sowers, Gerson Weiss.   

Abstract

The dynamics of reproductive hormones that characterize the menopausal transition (perimenopause) are incompletely understood, particularly in non-Caucasian women. The Study of Women's Health across the Nation (SWAN) is a multiethnic cohort study of 3302 women at seven sites who were aged 42-52 yr at baseline. All participants are seen annually to assess a variety of endpoints. A subcohort of 848 women undergoes further investigation of their daily patterns of reproductive hormones in the Daily Hormone Study (DHS). DHS enrollees annually complete a daily collection of first morning voided urine for an entire menstrual cycle or up to 50 d (whichever comes first). Chemiluminescent assays measured urinary LH and FSH, as well as metabolites of estradiol [estrone conjugates (E1c)] and progesterone [pregnanediol glucuronide (Pdg)]. Cycles were assessed for evidence of luteal activity and day of luteal transition using previously developed algorithms. Midreproductive-aged women who underwent similar daily urinary analyses served as historical controls. Correlates of cycle features were identified. Eight hundred thirty-three cycles were evaluable and had complete data on covariates. Six hundred seventy-four (80.9%) cycles had evidence of luteal activity, and 159 (19.1%) did not. Women who were at least 49 yr old were less likely to have cycles with luteal activity and had more variable cycle length, higher total-cycle FSH, and lower total-cycle Pdg. Compared with heavier women, those with body mass index less than 25 kg/m2 had shorter cycles and higher total-cycle LH, FSH, and Pdg but not E1c. Chinese- and Japanese-American women had overall lower adjusted total-cycle E1c excretion. Smoking was not significantly associated with cycle length or hormones. When compared with cycles of younger control women, the cycles of the SWAN DHS participants had higher gonadotropins, lower total integrated Pdg, and E1c levels that were not different, which suggests that the ovary retains sensitivity to elevated FSH in the early menopausal transition. In this cross-sectional study of women over age 42 who are premenopausal or in the early menopausal transition, there were important differences in the characteristics of cycles related to age, body mass index, and ethnicity. Comparisons to younger women indirectly support the inhibin hypothesis, which proposes that the initiating event in the menopausal transition is the loss of inhibin negative feedback on FSH secondary to a diminished follicular reserve.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181033     DOI: 10.1210/jc.2003-031578

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  71 in total

Review 1.  Menstruation and the menopausal transition.

Authors:  Siobán D Harlow; Pangaja Paramsothy
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

2.  Likelihood and Pseudo-likelihood Methods for Semiparametric Joint Models for a Primary Endpoint and Longitudinal Data.

Authors:  Erning Li; Daowen Zhang; Marie Davidian
Journal:  Comput Stat Data Anal       Date:  2007-08-15       Impact factor: 1.681

Review 3.  Management of the Perimenopause.

Authors:  Lara Delamater; Nanette Santoro
Journal:  Clin Obstet Gynecol       Date:  2018-09       Impact factor: 2.190

Review 4.  Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms.

Authors:  Amanda Allshouse; Jelena Pavlovic; Nanette Santoro
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

5.  Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles.

Authors:  Lauren Johnson; Mary D Sammel; Allison Schanne; Lara Lechtenberg; Maureen Prewitt; Clarisa Gracia
Journal:  Fertil Steril       Date:  2016-09-22       Impact factor: 7.329

6.  A factor analysis approach to examining relationships among ovarian steroid concentrations, gonadotrophin concentrations and menstrual cycle length characteristics in healthy, cycling women.

Authors:  E S Barrett; I Thune; S F Lipson; A-S Furberg; P T Ellison
Journal:  Hum Reprod       Date:  2012-12-18       Impact factor: 6.918

7.  Effects of gastric bypass surgery on female reproductive function.

Authors:  Richard S Legro; William C Dodson; Carol L Gnatuk; Stephanie J Estes; Allen R Kunselman; Juliana W Meadows; James S Kesner; Edward F Krieg; Ann M Rogers; Randy S Haluck; Robert N Cooney
Journal:  J Clin Endocrinol Metab       Date:  2012-10-12       Impact factor: 5.958

8.  Factors related to declining luteal function in women during the menopausal transition.

Authors:  N Santoro; S L Crawford; W L Lasley; J L Luborsky; K A Matthews; D McConnell; J F Randolph; E B Gold; G A Greendale; S G Korenman; L Powell; M F Sowers; G Weiss
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

9.  Association of adolescent obesity and lifetime nulliparity--the Study of Women's Health Across the Nation (SWAN).

Authors:  Alex J Polotsky; Susan M Hailpern; Joan H Skurnick; Joan C Lo; Barbara Sternfeld; Nanette Santoro
Journal:  Fertil Steril       Date:  2009-01-30       Impact factor: 7.329

10.  Partial recovery of luteal function after bariatric surgery in obese women.

Authors:  Dana Rochester; Akas Jain; Alex J Polotsky; Hanah Polotsky; Karen Gibbs; Barbara Isaac; Gohar Zeitlian; Cheryl Hickmon; Sophia Feng; Nanette Santoro
Journal:  Fertil Steril       Date:  2008-09-30       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.